% | 12% SDF | 38% SDF | |||||
---|---|---|---|---|---|---|---|
Study ID | Yee et al. [16] | Yee et al. [16] | |||||
Application frequency | One at baseline for 2 min | At baseline and every 12 months | At baseline and every 6 months | One at baseline for 2 min | At baseline and every 12 months | At baseline and every 6 months | |
Follow-up examinations | 6 months | 2.3 (0.2)† | 337/1051 (32.1)‡ | 346/1072 (32.3)‡ | 4.2 (0.3)† | 471/1073 (43.9)‡ | 449/1024 (43.8)‡ |
12 months | 1.7 (0.3)† | 409/1007 (40.6)‡ | 502/1046 (48.0)‡ | 3.4 (0.3)† | 540/1041 (51.9)‡ | 618/987 (62.6)‡ | |
18 months | 487/976 (49.9)‡ | 566/1028 (55.1)‡ | 649/1019 (63.7)‡ | 701/953 (73.6)‡ | |||
24 months | 1.5 (0.3)† | 504/937 (53.8)‡ | 591/999 (59.2)‡ | 2.1 (0.3)† | 620/971 (63.9)‡ | 698/912 (76.5)‡ | |
30 months | 512/927 (55.2)‡ | 578/987 (58.6)‡ | 650/971 (66.9)‡ | 685/905 (75.7)‡ | |||
2.59 (2.94)† | 2.85 (2.91)† | 3.20 (3.71)† | 3.49 (3.27)† |